血浆hsa_circ_005230在原发性肝细胞癌诊断和预后评估中的临床价值

doi:10.16352/j.issn.1001-6325.2023.09.1417

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (9): 1417-1422.doi: 10.16352/j.issn.1001-6325.2023.09.1417

血浆hsa_circ_005230在原发性肝细胞癌诊断和预后评估中的临床价值

依马木买买提江·阿布拉, 帕哈尔丁·白克热, 易超, 佟庆^*

新疆医科大学第三临床医学院肝胆胰外科,新疆乌鲁木齐 830000

收稿日期:2022-04-02 修回日期:2022-11-13 出版日期:2023-09-05 发布日期:2023-09-01
通讯作者: ^*tongqing2001@126.com
基金资助:
新疆自治区自然科学基金(2020D01C216)

Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma

Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing^*

Department of Hepatopancreatobiliary Surgery, the Third Clinical Medical College of Xinjiang Medical University, Urumqi 830000, China

Received:2022-04-02 Revised:2022-11-13 Online:2023-09-05 Published:2023-09-01
Contact: ^*tongqing2001@126.com

摘要/Abstract

摘要： 目的检测原发性肝细胞癌(HCC)血浆中环状RNA(circRNA) hsa_circ_005230表达水平,探讨其在HCC诊断和预后评估的临床价值。方法利用GEO数据库中的非编码RNA高通量测序数据筛选HCC(癌组织/癌旁组织)的circRNA表达情况。RT-qPCR检测60例HCC、30例乙型肝炎和30名健康人血浆中hsa_circ_005230表达水平,并分析其与HCC患者临床病理特征的关系。应用受试者工作特征(ROC)曲线评估hsa_circ_005230诊断HCC的临床价值。应用Kaplan-Meier法进行生存分析,Cox回归进行预后多因素分析。结果从GEO数据库中筛选出上调表达最明显的为hsa_circ_005230, HCC患者血浆中hsa_circ_005230表达水平显著高于乙型肝炎组和健康人组(P＜0.01);Hsa_circ_005230表达的增加与肿瘤大小(P＜0.05)和肿瘤淋巴结转移阶段密切相关(P＜0.01);ROC分析显示,血浆hsa_circ_005230鉴别HCC与健康人的曲线下面积(AUC)为0.69,敏感度为70%,特异度为82%。高hsa_circ_005230水平患者的总生存率显著低于低hsa_circ_005230水平患者。单因素分析显示,甲胎蛋白(AFP)(P＜0.01)和hsa_circ_005230(P＜0.01)为影响HCC预后的相关因素。Cox多变量分析显示hsa_circ_005230是 HCC 患者的独立预后指标。结论 Hsa_circ_005230可能作为诊断HCC和预后评估的新的生物学标志物。

关键词: 肝细胞癌, 环状RNA, hsa_circ_005230, 诊断, 预后

Abstract: Objective To detect the expression level of circular RNA (circRNA) hsa_circ_005230 in the plasma of primary hepatocellular carcinoma (HCC), and to explore its clinical value in the diagnosis and prognosis of HCC. Methods The non-coding RNA high-throughput sequencing data in the GEO database was used to screen the circRNA expression in HCC (cancer tissue/paracancerous tissue). RT-qPCR was used to detect hsa_circ_005230 in the plasma of 60 HCC patients, 30 hepatitis B patients and 30 healthy people. Expression levels and their relationship with clinicopathological characteristics of HCC patients were evaluated. The receiver operating characteristic(ROC) curve to evaluate the clinical value of hsa_circ_005230 in the diagnosis of HCC. Survival analysis was performed by Kaplan-Meier method, and multivariate prognostic analysis was performed by Cox regression. Results The most significant up-regulated expression was found in hsa_circ_005230 from the GEO database. The expression level of hsa_circ_005230 in plasma of HCC patients was significantly higher than that of hepatitis B group and healthy control group (P＜0.01); The increase of hsa_circ_005230 expression was related to tumor size (P＜0.05) and to the stage of tumor lymph node metastasis(P＜0.01); ROC analysis showed that the area under the ROC curve (AUC) of plasma hsa_circ_005230 in differentiating HCC from healthy people was 0.69, the sensitivity was 70%,and the specificity was 82 %.The overall survival rate of patients with high hsa_circ_005230 level was significantly lower than that of patients with low hsa_circ_005230 level. Univariate analysis showed that alpa-fetoprotein(AFP)(P＜0.01) and hsa_circ_005230 (P＜0.01) were related factors affecting the prognosis of HCC. Cox multivariate analysis revealed that hsa_circ_005230 was an independent prognostic indicator in HCC patients. Conclusions The hsa_circ_005230 may be used as a new biological marker for the diagnosis and prognostic evaluation of HCC.

Key words: hepatocellular carcinoma, circular RNA, hsa_circ_005230, diagnosis, prognosis

中图分类号:

R622
R73

依马木买买提江·阿布拉, 帕哈尔丁·白克热, 易超, 佟庆. 血浆hsa_circ_005230在原发性肝细胞癌诊断和预后评估中的临床价值[J]. 基础医学与临床, 2023, 43(9): 1417-1422.

Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing. Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2023.09.1417

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2023/V43/I9/1417

参考文献

[1]Yang L, Song C, Chen Y, et al. Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236[J]. J Cell Biochem, 2019, 120:15553-15560.
[2]Zhao M, Dong G, Meng Q, et al. Circ_OMER1 enhances the inhibition of miR22 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells[J]. J Cell Biochem, 2020, 121:4440-4449.
[3]Afrin R, Arumugam S, Rahman A, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation[J]. Int Immunopharmacol, 2017, 44:174-182.
[4]Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer[J]. Breast Cancer, 2018, 25:1-7.
[5]赵钰珊,冀梦蝶,董昱诚,等.肝细胞癌中EZH2基因相关的表观遗传调控机制[J].基础医学与临床,2022,42:864-870.
[6]Yao T, Chen Q, Fu L, et al. Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases[J]. Hepatol Res, 2017, 47:497-504.
[7]Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer[J]. Mol Cancer, 2017, 16:94-101.
[8]黄海良,丁伟伟,李冬雪. CRNDE过表达促进人肝癌细胞系HepG2增殖和迁移[J].基础医学与临床, 2020, 40:219-223.
[9]Qi H, Sun Y, Jiang Y, et al. Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-1238[J]. J Cell Biochem, 2019, 5:11-19.
[10]Zhang LW, Wang B, Yang JX, et al. Circ-PRMT5 stimulates migration in esophageal cancer by binding miR-203[J]. Eur Rev Med Pharmacol Sci, 2020, 24:9965-9972.
[11]Yang L, Song C, Chen Y, et al. Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236[J]. J Cell Biochem, 2019, 120:15553-15560.
[12]Shen GQ, Girelli D, Li L, et al. A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 gene.[J]. Circ Cardiovasc Genet, 2014, 7:514-520.
[13]Shaohang, Cai, Zejin, et al. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome:[J]. United European Gastroenterol J, 2018, 6:558-566.
[14]Frisk P, Aggefors K, Cars T, et al. Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden[J]. Eur J Clin Pharmacol, 2018, 74:971-978.
[15]Mónica G, Sandra G, Miguel HK, et al. Differential roles, crosstalk and response to the antifungal protein AfpB in the three mitogen-activated protein kinases (MAPK) pathways of the citrus postharvest pathogen penicillium digitatum.[J]. Fungal Genet Biol, 2018, 124:17-28.

血浆hsa_circ_005230在原发性肝细胞癌诊断和预后评估中的临床价值

Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	贡子琦, 吴晓雯, 郭倩, 郭军, 孔燕. PTEN突变对黏膜黑色素瘤患者临床病理特征及预后的影响[J]. 基础医学与临床, 2023, 43(9): 1341-1345.
[2]	颜晨红, 金儿. 外泌体PD-L1在非小细胞肺癌诊断和治疗上的研究进展[J]. 基础医学与临床, 2023, 43(9): 1457-1461.
[3]	林映雪, 崔海鹏, 王爱国, 姚银辉, 赵娟. 雷帕霉素减缓转基因小鼠肝细胞癌进展[J]. 基础医学与临床, 2023, 43(8): 1241-1246.
[4]	郑彬彬, 林淑莹, 李德隆, 陈杰, 黄子成. 环状RNA ATP2B1靶向miR-452-5p降低胃癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2023, 43(6): 882-888.
[5]	邹瑾, 何向蕾, 张欣, 陈日萍, 张宇, 胡帅悦, 应士波. 蛋白质精氨酸残基化学修饰酶PADs与PRMTs在人肝癌细胞系中的表达[J]. 基础医学与临床, 2023, 43(6): 898-903.
[6]	张永梅, 张志敏, 周洁, 潘志兰, 冯丽倩, 杨彦. LncRNA CBR3-AS1在多发性骨髓瘤中的表达及临床意义[J]. 基础医学与临床, 2023, 43(6): 948-952.
[7]	冀梦蝶, 苑赞, 卞晓翠, 杨玉容, 郭鑫, 王琦, 陈阳. 人肝癌细胞系HepG2和Huh7中的基因组拷贝数变异分析[J]. 基础医学与临床, 2023, 43(6): 960-966.
[8]	高欣, 于永波, 王海存, 姜兴明, 王志东. 环状RNA核受体相互作用蛋白1对肿瘤发生发展的调控机制研究进展[J]. 基础医学与临床, 2023, 43(5): 827-832.
[9]	薛剑超, 王亚东, 李博文, 刘新宇, 梁乃新, 李单青. DNA甲基化在肺癌发生及预后中作用的研究进展[J]. 基础医学与临床, 2023, 43(3): 514-518.
[10]	谢晓婷, 张雷, 张莉, 董凤, 刘颖, 李光华, 杨兴. ASH2L在幽门螺旋杆菌感染的人胃癌细胞系中的表达及临床意义[J]. 基础医学与临床, 2023, 43(3): 367-373.
[11]	李雨喋, 王宏宇, 韩松, 李俊发. 激活素A通过少突胶质细胞ACVR1C改善缺血性卒中小鼠神经功能的预后[J]. 基础医学与临床, 2023, 43(3): 380-385.
[12]	黄驿胜, 叶启文, 王竞枫. miR-203a-3p抑制人肝癌细胞系增殖[J]. 基础医学与临床, 2023, 43(1): 87-94.
[13]	孙爱华, 赵艳秋, 王继灵. 老年慢性阻塞性肺部疾病急性加重期患者住院死亡的危险因素及预后[J]. 基础医学与临床, 2022, 42(9): 1414-1418.
[14]	谢思安, 陈奕阳, 徐俊玄, 宁婷婷, 张楠, 朱圣韬, 张澍田. PTOV1表达水平对结直肠癌患者预后的影响[J]. 基础医学与临床, 2022, 42(8): 1176-1181.
[15]	樊佳赛, 杜艺菲, 许佳颖, 陈思臻, 高永桧, 任景怡. 基于中医证候和机器学习构建慢性心力衰竭中西医结合预后模型[J]. 基础医学与临床, 2022, 42(8): 1169-1175.